<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Anijarv TE</submitter><funding>European Research Council</funding><pagination>8232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12413461</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>The distribution of tau pathology in Alzheimer's disease (AD) shows remarkable inter-individual heterogeneity, including hemispheric asymmetry. However, the factors driving this asymmetry remain poorly understood. Here we explore whether tau asymmetry is linked to i) reduced inter-hemispheric brain connectivity (potentially restricting tau spread), or ii) asymmetry in amyloid-beta (Aβ) distribution (indicating greater hemisphere-specific vulnerability to AD pathology). We include 452 participants from the Swedish BioFINDER-2 cohort with evidence of both Aβ pathology (CSF Aβ42/40 or neocortical Aβ-PET) and tau pathology (temporal tau-PET), categorising them as left asymmetric (n = 102), symmetric (n = 306), or right asymmetric (n = 44) based on temporal lobe tau-PET uptake distribution. We assess edge-wise inter-hemispheric functional (RSfMRI; n = 318) and structural connectivity (dMRI; n = 352) but find no association between tau asymmetry and connectivity. In contrast, we observe a strong association between tau and Aβ laterality patterns based on PET uptake (n = 233; β = 0.632, p &lt; 0.001), which we replicate in three independent cohorts (n = 234; β = 0.535, p &lt; 0.001). In a longitudinal Aβ-positive sample, we show that baseline Aβ asymmetry predicts progression of tau laterality over time (n = 289; β = 0.025, p = 0.028). These findings suggest that tau asymmetry is not associated with a weaker inter-hemispheric connectivity but might reflect hemispheric differences in vulnerability to Aβ pathology, underscoring the role of regional vulnerability in determining the distribution of AD pathology.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease.</pubmed_title><pmcid>PMC12413461</pmcid><funding_grant_id>101096455</funding_grant_id><pubmed_authors>Strandberg O</pubmed_authors><pubmed_authors>Karlsson L</pubmed_authors><pubmed_authors>Vogel JW</pubmed_authors><pubmed_authors>Beckett L</pubmed_authors><pubmed_authors>Jack CR</pubmed_authors><pubmed_authors>Landau S</pubmed_authors><pubmed_authors>Toga AW</pubmed_authors><pubmed_authors>Alzheimer’s Disease Neuroimaging Initiative</pubmed_authors><pubmed_authors>Rivera-Mindt M</pubmed_authors><pubmed_authors>Okonkwo O</pubmed_authors><pubmed_authors>Green RC</pubmed_authors><pubmed_authors>Perrin RJ</pubmed_authors><pubmed_authors>Jagust W</pubmed_authors><pubmed_authors>Saykin AJ</pubmed_authors><pubmed_authors>Aisen P</pubmed_authors><pubmed_authors>Palmqvist S</pubmed_authors><pubmed_authors>Hansson O</pubmed_authors><pubmed_authors>van Westen D</pubmed_authors><pubmed_authors>Weiner M</pubmed_authors><pubmed_authors>Pichet Binette A</pubmed_authors><pubmed_authors>Spotorno N</pubmed_authors><pubmed_authors>Ossenkoppele R</pubmed_authors><pubmed_authors>Stomrud E</pubmed_authors><pubmed_authors>Ahmadi K</pubmed_authors><pubmed_authors>Rittmo J</pubmed_authors><pubmed_authors>Tosun D</pubmed_authors><pubmed_authors>Smith R</pubmed_authors><pubmed_authors>Behjat HH</pubmed_authors><pubmed_authors>Anijarv TE</pubmed_authors><pubmed_authors>Collij LE</pubmed_authors><pubmed_authors>Mattsson-Carlgren N</pubmed_authors><pubmed_authors>Shaw LM</pubmed_authors><pubmed_authors>Lee EB</pubmed_authors><pubmed_authors>Nho K</pubmed_authors><pubmed_authors>Harvey D</pubmed_authors><pubmed_authors>Petersen R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease.</name><description>The distribution of tau pathology in Alzheimer's disease (AD) shows remarkable inter-individual heterogeneity, including hemispheric asymmetry. However, the factors driving this asymmetry remain poorly understood. Here we explore whether tau asymmetry is linked to i) reduced inter-hemispheric brain connectivity (potentially restricting tau spread), or ii) asymmetry in amyloid-beta (Aβ) distribution (indicating greater hemisphere-specific vulnerability to AD pathology). We include 452 participants from the Swedish BioFINDER-2 cohort with evidence of both Aβ pathology (CSF Aβ42/40 or neocortical Aβ-PET) and tau pathology (temporal tau-PET), categorising them as left asymmetric (n = 102), symmetric (n = 306), or right asymmetric (n = 44) based on temporal lobe tau-PET uptake distribution. We assess edge-wise inter-hemispheric functional (RSfMRI; n = 318) and structural connectivity (dMRI; n = 352) but find no association between tau asymmetry and connectivity. In contrast, we observe a strong association between tau and Aβ laterality patterns based on PET uptake (n = 233; β = 0.632, p &lt; 0.001), which we replicate in three independent cohorts (n = 234; β = 0.535, p &lt; 0.001). In a longitudinal Aβ-positive sample, we show that baseline Aβ asymmetry predicts progression of tau laterality over time (n = 289; β = 0.025, p = 0.028). These findings suggest that tau asymmetry is not associated with a weaker inter-hemispheric connectivity but might reflect hemispheric differences in vulnerability to Aβ pathology, underscoring the role of regional vulnerability in determining the distribution of AD pathology.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T22:24:49.468Z</modification><creation>2026-04-08T06:12:34.284Z</creation></dates><accession>S-EPMC12413461</accession><cross_references><pubmed>40913038</pubmed><doi>10.1038/s41467-025-63564-2</doi></cross_references></HashMap>